ArticleHepatology (Baltimore, Md.)2020

Risk of Cirrhosis and Hepatocellular Cancer in Patients With NAFLD and Normal Liver Enzymes.

Yamini Natarajan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.